Related Experiment Video
Updated: May 22, 2026

Modified Yeast-Two-Hybrid System to Identify Proteins Interacting with the Growth Factor Progranulin
Published on: January 17, 2012
Regulation of microglial activation by progranulin through the NF-κB pathway in subarachnoid hemorrhage and its
Ziliang Hu1, Pan Lv2, Wenting Lan3
1Department of Neurosurgery, Ningbo Key Laboratory of Nervous System and Brain Function, The First Affiliated Hospital of Ningbo University, Ningbo, Zhejiang 315010, China; Department of Clinical Laboratory, The First Affiliated Hospital of Ningbo University, Ningbo, Zhejiang 315010, China; Department of Neurosurgery, Ningbo Hangzhou Bay Hospital, Ningbo, Zhejiang, China; Department of Neurosurgery, Ningbo Branch, Ren Ji Hospital, Shanghai Jiao Tong University School of Medicine, Ningbo, Zhejiang 315336, China.
Abstract:
Subarachnoid hemorrhage (SAH) is a severe cerebrovascular condition commonly associated with white matter injury and subsequent cognitive dysfunction. Emerging evidence suggests that progranulin (PGRN) is involved in neuroinflammation regulation and myelin integrity maintenance. This study aimed to investigate the role of PGRN in SAH and to elucidate its potential neuroprotective mechanisms. Magnetic resonance imaging (MRI) and cerebrospinal fluid (CSF) samples from clinical patients were analyzed, with inflammatory factors measured by enzyme-linked immunosorbent assay (ELISA). In a rat SAH model, myelin basic protein (MBP) and ionized calcium-binding adapter molecule 1 (IBA-1) expression were assessed by Western blotting and immunofluorescence, and transcriptomic analysis was performed to identify gene expression changes. Cognitive function was evaluated using the Morris water maze. Transcriptomic results showed that genes altered after SAH were mainly enriched in pathways related to glial cell differentiation, myelin integrity, and immune regulation. Clinical MRI and CSF findings suggested an association between SAH, inflammation, and cognitive impairment. In animal experiments, increased PGRN expression was associated with reduced brain injury and improved myelin integrity. Behavioral testing indicated that treatment with the PGRN enhancer AL001 shortened escape latency and increased time spent in the target quadrant, suggesting improved cognitive performance. These findings suggest that PGRN may exert neuroprotective effects after SAH by modulating glial activity and maintaining myelin integrity, and that AL001 may represent a potential therapeutic approach for alleviating cognitive dysfunction following SAH.
More Related Videos
Related Concept Videos
NF-κB-dependent Signaling Pathway
NF-κB-dependent Signaling Mechanism
The heterodimer of NF-κB...
Bacterial Meningitis II: Pathophysiology
Neurogenesis and Regeneration of Nervous Tissue

